-
WuXi Biologics rises more than 6%! For a license-out deal with GSK
Time of Update: 2023-02-01
In addition to WuXi Biologics, companies with self-developed bispecific antibody technology platforms such as Harbour Biologics have also received hundreds of millions of dollars in transactions through external licensing and cooperation.
-
Sticky bacteria are more resistant to antibiotics, leading to high patient mortality
Time of Update: 2023-01-06
By analyzing samples that produced the esbl strains, the researchers found that many HMV strains also carry a higher percentage of viral disease-causing genes, and traditional drugs are ineffective against them.
-
Sticky bacteria are more resistant to antibiotics, leading to high patient mortality
Time of Update: 2023-01-06
By analyzing samples that produced the esbl strains, the researchers found that many HMV strains also carry a higher percentage of viral disease-causing genes, and traditional drugs are ineffective against them.
-
Is it feasible to stop using animals in biomedical research
Time of Update: 2022-10-25
com/s/MS4nZw3b_Kqo_-ZbGHBLwg Recently, the United States introduced a new bill aimed at reducing animal testing in the future.
com/s/MS4nZw3b_Kqo_-ZbGHBLwg Recently, the United States introduced a new bill aimed at reducing animal testing in the future.
-
More than 60% of the courier patients achieved symptom improvement, and two phase 3 clinical results of broad-spectrum antibacterial drugs were positive
Time of Update: 2022-06-07
▎WuXi AppTec Content Team Editor A few days ago, SCYNEXIS announced that its innovative oral antifungal investigational therapy ibrexafungerp has received positive interim results in two Phase 3 clinical trials, continuing to demonstrate ibrexafungerp's potential to treat difficult-to-treat fungal infections in hospital settings .
-
Luoxin Pharmaceutical's Edaravone Injection passed the consistency evaluation of generic drugs
Time of Update: 2022-05-29
On January 9, Luoxin Pharmaceutical announced that its subsidiary Shandong Luoxin had recently received the "Approval Notice for Supplementary Drug Application" for Edaravone Injection approved and issued by the State Food and Drug Administration .
-
Comparison of pharmaceutical output value and number of enterprises in various provinces in China
Time of Update: 2022-04-29
According to the statistics of the Research and Planning Center of the Pharmaceutical Economics News, the total output value of China's pharmaceutical industry during the "13th Five-Year Plan" period is the seven major pharmaceutical industry sub-sectors (chemical preparations, Chinese patent medicine preparations, chemical raw materials, biological products, medical equipment, hygiene materials and pharmaceutical supplies).
-
This study shows possible commonalities between many neurodegenerative diseases
Time of Update: 2022-04-27
"We've discovered that a protein called TMEM106B can form fibers, a behavior that wasn't known before," said Xinyu Xiang, a former member of the Fitzpatrick lab at the Zuckerman Institute and now a graduate student in Stanford's Department of Structural Biology.
-
Another city
Time of Update: 2022-03-09
Recently, Hengrui Medicine's Class 1 new drug Proline Henggliflozin Tablets (trade name: Ruiqin) was officially approved for marketing, which is also the first domestically-made innovative SGLT2 inhibitor approved so far .
-
The first brother of the pharmaceutical stock flashed a market value of over 40 billion
Time of Update: 2022-01-27
As of the close on December 31, 2021, 14 pharmaceutical stocks including Mindray Medical, WuXi AppTec, Hengrui Medicine, and Pien Tze Huang have a market value of 100 billion yuan .
-
[Live] The measurement engineer who has been deeply involved in the industry for 10 years explains the selection of temperature measuring instruments in detail
Time of Update: 2022-01-25
"How to choose a temperature measuring instrument" Click on the picture to enter the live broadcast room.
At 14:00 on January 12, "How to choose a temperature measuring instrument" will be broadcast live, please pay attention!
-
2022.01.04
Time of Update: 2022-01-07
On January 4, 2022, CDE continuously issued 4 technical guidelines, three of which are clinically related : "Technical Guidelines for Writing Safety Reference Information in the Researcher's Handb
-
Shengyuan filter element SYAF-A006 SYAF-H006
Time of Update: 2021-12-01
01ppmw/w residual oil content) Multi-layer fiber media and media filter screen to filter out large particles, and filter the air before entering the second stage filter 2 -level multi-layer bonded fiber media to filter out fine agglomerates The inner and outer filter elements are anti-corrosion, and the outer coating film closed foam sleeve Class H is suitable for filtering out oil vapor and hydrocarbon vapor that carbon can usually absorb; it can filter solid particles as small as 0.
-
China's first CAR-T therapy: the patient's cancer cells are cleared within two months
Time of Update: 2021-10-01
China's first CAR-T treatment: the patient's cancer cells were eliminated within two months .
2 million yuan can make cancer cells disappear and make everyone's eyes bright: Are cancer patients saved?China's first approved CAR-T drug, Yikaida, was approved for marketing in June this year .
-
North China Pharmaceutical's Class 1 new drug Omotivizumab for rabies is about to be approved
Time of Update: 2021-08-15
On August 5, the official website of NMPA showed that North China Pharmaceutical's Class 1 new drug omiltivizumab has entered the approval stage and is expected to be approved in the near future (acceptance number: CXSS2000040) for passive immunization of patients exposed to rabies virus .
